APO Research, Inc.

APO RESEARCH · REPORT

Drug Delivery Devices

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

Product & engineering

Understand the product.

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

Selected research

Industry Growth & Trends

Global Drug Delivery Devices Industry Growth and Trends Forecast to 2032

Market perspective

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

According to APO Research, the global Drug Delivery Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Drug Delivery Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Delivery Devices market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Delivery Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Delivery Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug Delivery Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Delivery Devices Market by Company

Cipla

Baxter International

Nipro Corporation

Roche

Boehringer Ingelheim

Allergan

3M

BD

Catalent

Valeant Pharmaceuticals

Bayer AG

Chiesi

Phillips-Medisize

Johnson & Johnson

Shandong Weigao

Pfizer

B.Braun

Novartis AG

Zhengkang

Gerresheimer

COVIDIEN Medtronic

Schott forma vitrum

Alkermes

Skyepharma

Drug Delivery Devices Segment by Type

Injection Type

Mucosal Type

Implanted Type

Others Type

Drug Delivery Devices Segment by Application

Pharmaceutical Companies

Hospitals

Clinics

Other

Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug Delivery Devices companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug Delivery Devices Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug Delivery Devices Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug Delivery Devices Market Share by Region (2021-2026) Table 4. Global Drug Delivery Devices Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug Delivery Devices Market Share by Region (2027-2032) Table 6. Global Drug Delivery Devices Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug Delivery Devices Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug Delivery Devices Market Size Share by Type (2021-2026) Table 9. Global Drug Delivery Devices Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug Delivery Devices Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug Delivery Devices Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug Delivery Devices Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug Delivery Devices Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug Delivery Devices Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug Delivery Devices Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug Delivery Devices Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug Delivery Devices Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug Delivery Devices Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug Delivery Devices Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug Delivery Devices Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug Delivery Devices Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug Delivery Devices Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug Delivery Devices Market Size Share by Application (2021-2026) Table 24. Global Drug Delivery Devices Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug Delivery Devices Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug Delivery Devices Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug Delivery Devices Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug Delivery Devices Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug Delivery Devices Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug Delivery Devices Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug Delivery Devices Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug Delivery Devices Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug Delivery Devices Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug Delivery Devices Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug Delivery Devices Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug Delivery Devices Industry Trends Table 37. Drug Delivery Devices Industry Drivers Table 38. Drug Delivery Devices Industry Opportunities and Challenges Table 39. Drug Delivery Devices Industry Restraints Table 40. Global Drug Delivery Devices Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug Delivery Devices Revenue Market Share by Company (2021-2026) Table 42. Global Drug Delivery Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug Delivery Devices Key Company Headquarters & Area Served Table 44. Global Drug Delivery Devices Company, Product Type & Application Table 45. Global Drug Delivery Devices Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Cipla Company Information Table 49. Cipla Business Overview Table 50. Cipla Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Cipla Drug Delivery Devices Product Portfolio Table 52. Cipla Recent Development Table 53. Baxter International Company Information Table 54. Baxter International Business Overview Table 55. Baxter International Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Baxter International Drug Delivery Devices Product Portfolio Table 57. Baxter International Recent Development Table 58. Nipro Corporation Company Information Table 59. Nipro Corporation Business Overview Table 60. Nipro Corporation Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Nipro Corporation Drug Delivery Devices Product Portfolio Table 62. Nipro Corporation Recent Development Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Roche Drug Delivery Devices Product Portfolio Table 67. Roche Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Drug Delivery Devices Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Allergan Company Information Table 74. Allergan Business Overview Table 75. Allergan Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Allergan Drug Delivery Devices Product Portfolio Table 77. Allergan Recent Development Table 78. 3M Company Information Table 79. 3M Business Overview Table 80. 3M Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. 3M Drug Delivery Devices Product Portfolio Table 82. 3M Recent Development Table 83. BD Company Information Table 84. BD Business Overview Table 85. BD Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. BD Drug Delivery Devices Product Portfolio Table 87. BD Recent Development Table 88. Catalent Company Information Table 89. Catalent Business Overview Table 90. Catalent Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Catalent Drug Delivery Devices Product Portfolio Table 92. Catalent Recent Development Table 93. Valeant Pharmaceuticals Company Information Table 94. Valeant Pharmaceuticals Business Overview Table 95. Valeant Pharmaceuticals Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio Table 97. Valeant Pharmaceuticals Recent Development Table 98. Bayer AG Company Information Table 99. Bayer AG Business Overview Table 100. Bayer AG Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bayer AG Drug Delivery Devices Product Portfolio Table 102. Bayer AG Recent Development Table 103. Chiesi Company Information Table 104. Chiesi Business Overview Table 105. Chiesi Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Chiesi Drug Delivery Devices Product Portfolio Table 107. Chiesi Recent Development Table 108. Phillips-Medisize Company Information Table 109. Phillips-Medisize Business Overview Table 110. Phillips-Medisize Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Phillips-Medisize Drug Delivery Devices Product Portfolio Table 112. Phillips-Medisize Recent Development Table 113. Johnson & Johnson Company Information Table 114. Johnson & Johnson Business Overview Table 115. Johnson & Johnson Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Johnson & Johnson Drug Delivery Devices Product Portfolio Table 117. Johnson & Johnson Recent Development Table 118. Shandong Weigao Company Information Table 119. Shandong Weigao Business Overview Table 120. Shandong Weigao Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Shandong Weigao Drug Delivery Devices Product Portfolio Table 122. Shandong Weigao Recent Development Table 123. Pfizer Company Information Table 124. Pfizer Business Overview Table 125. Pfizer Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Pfizer Drug Delivery Devices Product Portfolio Table 127. Pfizer Recent Development Table 128. B.Braun Company Information Table 129. B.Braun Business Overview Table 130. B.Braun Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. B.Braun Drug Delivery Devices Product Portfolio Table 132. B.Braun Recent Development Table 133. Novartis AG Company Information Table 134. Novartis AG Business Overview Table 135. Novartis AG Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Novartis AG Drug Delivery Devices Product Portfolio Table 137. Novartis AG Recent Development Table 138. Zhengkang Company Information Table 139. Zhengkang Business Overview Table 140. Zhengkang Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Zhengkang Drug Delivery Devices Product Portfolio Table 142. Zhengkang Recent Development Table 143. Gerresheimer Company Information Table 144. Gerresheimer Business Overview Table 145. Gerresheimer Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Gerresheimer Drug Delivery Devices Product Portfolio Table 147. Gerresheimer Recent Development Table 148. COVIDIEN Medtronic Company Information Table 149. COVIDIEN Medtronic Business Overview Table 150. COVIDIEN Medtronic Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. COVIDIEN Medtronic Drug Delivery Devices Product Portfolio Table 152. COVIDIEN Medtronic Recent Development Table 153. Schott forma vitrum Company Information Table 154. Schott forma vitrum Business Overview Table 155. Schott forma vitrum Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Schott forma vitrum Drug Delivery Devices Product Portfolio Table 157. Schott forma vitrum Recent Development Table 158. Alkermes Company Information Table 159. Alkermes Business Overview Table 160. Alkermes Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Alkermes Drug Delivery Devices Product Portfolio Table 162. Alkermes Recent Development Table 163. Skyepharma Company Information Table 164. Skyepharma Business Overview Table 165. Skyepharma Drug Delivery Devices Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Skyepharma Drug Delivery Devices Product Portfolio Table 167. Skyepharma Recent Development Table 168. North America Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Drug Delivery Devices Market Share by Country (2021-2026) Table 171. North America Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 173. Europe Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Drug Delivery Devices Market Share by Country (2021-2026) Table 176. Europe Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Drug Delivery Devices Market Share by Country (2021-2026) Table 181. Asia-Pacific Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 183. Latin America Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Drug Delivery Devices Market Share by Country (2021-2026) Table 186. Latin America Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 188. Middle East & Africa Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East & Africa Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East & Africa Drug Delivery Devices Market Share by Country (2021-2026) Table 191. Middle East & Africa Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East & Africa Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug Delivery Devices Product Image Figure 3. Global Drug Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug Delivery Devices Market Share by Region: 2025 VS 2032 Figure 6. Global Drug Delivery Devices Market Share by Region (2021-2032) Figure 7. North America Drug Delivery Devices Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug Delivery Devices Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug Delivery Devices Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug Delivery Devices Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug Delivery Devices Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Injection Type Image Figure 13. Global Injection Type Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Mucosal Type Image Figure 15. Global Mucosal Type Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Implanted Type Image Figure 17. Global Implanted Type Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Type Image Figure 19. Global Others Type Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Drug Delivery Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Drug Delivery Devices Market Share by Type 2025 VS 2032 Figure 22. North America Drug Delivery Devices Market Size Share by Type (2021-2032) Figure 23. Europe Drug Delivery Devices Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Drug Delivery Devices Market Size Share by Type (2021-2032) Figure 25. Latin America Drug Delivery Devices Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Drug Delivery Devices Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Companies Image Figure 28. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinics Image Figure 32. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Drug Delivery Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Drug Delivery Devices Market Share by Application 2025 VS 2032 Figure 37. North America Drug Delivery Devices Market Size Share by Application (2021-2032) Figure 38. Europe Drug Delivery Devices Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Drug Delivery Devices Market Size Share by Application (2021-2032) Figure 40. Latin America Drug Delivery Devices Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Drug Delivery Devices Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Drug Delivery Devices Market Share by Country (2021-2032) Figure 47. Europe Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Drug Delivery Devices Market Share by Country (2021-2032) Figure 50. Asia-Pacific Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Drug Delivery Devices Market Share by Country (2021-2032) Figure 53. Latin America Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Drug Delivery Devices Market Share by Country (2021-2032) Figure 56. Middle East & Africa Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Drug Delivery Devices Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Type
  • Mucosal Type
  • Implanted Type
  • Others Type
Applications
  • Pharmaceutical Companies
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Cipla
  • Baxter International
  • Nipro Corporation
  • Roche
  • Boehringer Ingelheim
  • Allergan
  • 3M
  • BD
  • Catalent
  • Valeant Pharmaceuticals
  • Bayer AG
  • Chiesi
  • Phillips-Medisize
  • Johnson & Johnson
  • Shandong Weigao
  • Pfizer
  • B.Braun
  • Novartis AG
  • Zhengkang
  • Gerresheimer
  • COVIDIEN Medtronic
  • Schott forma vitrum
  • Alkermes
  • Skyepharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug Delivery Devices Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug Delivery Devices Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug Delivery Devices Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug Delivery Devices Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug Delivery Devices Market Size (2021-2032)
  8. 1.5.1 North America Drug Delivery Devices Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug Delivery Devices Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug Delivery Devices Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug Delivery Devices Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug Delivery Devices Market Size Growth Rate (2021-2032)
2 Drug Delivery Devices Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Injection Type
  3. 2.1.2 Mucosal Type
  4. 2.1.3 Implanted Type
  5. 2.1.4 Others Type
  6. 2.2 Global Drug Delivery Devices Market Size by Type
  7. 2.2.1 Global Drug Delivery Devices Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Drug Delivery Devices Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Drug Delivery Devices Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Drug Delivery Devices Market Size by Regions
  11. 2.3.1 North America Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
3 Drug Delivery Devices Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Companies
  3. 3.1.2 Hospitals
  4. 3.1.3 Clinics
  5. 3.1.4 Other
  6. 3.2 Global Drug Delivery Devices Market Size by Application
  7. 3.2.1 Global Drug Delivery Devices Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Drug Delivery Devices Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Drug Delivery Devices Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Drug Delivery Devices Market Size by Regions
  11. 3.3.1 North America Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug Delivery Devices Industry Trends
  2. 4.2 Drug Delivery Devices Industry Drivers
  3. 4.3 Drug Delivery Devices Industry Opportunities and Challenges
  4. 4.4 Drug Delivery Devices Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug Delivery Devices Revenue (2021-2026)
  2. 5.2 Global Drug Delivery Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug Delivery Devices Key Company Headquarters & Area Served
  4. 5.4 Global Drug Delivery Devices Company, Product Type & Application
  5. 5.5 Global Drug Delivery Devices Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug Delivery Devices Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug Delivery Devices Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug Delivery Devices Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Cipla
  2. 6.1.1 Cipla Company Information
  3. 6.1.2 Cipla Business Overview
  4. 6.1.3 Cipla Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Cipla Drug Delivery Devices Product Portfolio
  6. 6.1.5 Cipla Recent Developments
  7. 6.2 Baxter International
  8. 6.2.1 Baxter International Company Information
  9. 6.2.2 Baxter International Business Overview
  10. 6.2.3 Baxter International Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Baxter International Drug Delivery Devices Product Portfolio
  12. 6.2.5 Baxter International Recent Developments
  13. 6.3 Nipro Corporation
  14. 6.3.1 Nipro Corporation Company Information
  15. 6.3.2 Nipro Corporation Business Overview
  16. 6.3.3 Nipro Corporation Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
  18. 6.3.5 Nipro Corporation Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Roche Drug Delivery Devices Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Boehringer Ingelheim
  26. 6.5.1 Boehringer Ingelheim Company Information
  27. 6.5.2 Boehringer Ingelheim Business Overview
  28. 6.5.3 Boehringer Ingelheim Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
  30. 6.5.5 Boehringer Ingelheim Recent Developments
  31. 6.6 Allergan
  32. 6.6.1 Allergan Company Information
  33. 6.6.2 Allergan Business Overview
  34. 6.6.3 Allergan Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Allergan Drug Delivery Devices Product Portfolio
  36. 6.6.5 Allergan Recent Developments
  37. 6.7 3M
  38. 6.7.1 3M Company Information
  39. 6.7.2 3M Business Overview
  40. 6.7.3 3M Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 3M Drug Delivery Devices Product Portfolio
  42. 6.7.5 3M Recent Developments
  43. 6.8 BD
  44. 6.8.1 BD Company Information
  45. 6.8.2 BD Business Overview
  46. 6.8.3 BD Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 BD Drug Delivery Devices Product Portfolio
  48. 6.8.5 BD Recent Developments
  49. 6.9 Catalent
  50. 6.9.1 Catalent Company Information
  51. 6.9.2 Catalent Business Overview
  52. 6.9.3 Catalent Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Catalent Drug Delivery Devices Product Portfolio
  54. 6.9.5 Catalent Recent Developments
  55. 6.10 Valeant Pharmaceuticals
  56. 6.10.1 Valeant Pharmaceuticals Company Information
  57. 6.10.2 Valeant Pharmaceuticals Business Overview
  58. 6.10.3 Valeant Pharmaceuticals Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
  60. 6.10.5 Valeant Pharmaceuticals Recent Developments
  61. 6.11 Bayer AG
  62. 6.11.1 Bayer AG Company Information
  63. 6.11.2 Bayer AG Business Overview
  64. 6.11.3 Bayer AG Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bayer AG Drug Delivery Devices Product Portfolio
  66. 6.11.5 Bayer AG Recent Developments
  67. 6.12 Chiesi
  68. 6.12.1 Chiesi Company Information
  69. 6.12.2 Chiesi Business Overview
  70. 6.12.3 Chiesi Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Chiesi Drug Delivery Devices Product Portfolio
  72. 6.12.5 Chiesi Recent Developments
  73. 6.13 Phillips-Medisize
  74. 6.13.1 Phillips-Medisize Company Information
  75. 6.13.2 Phillips-Medisize Business Overview
  76. 6.13.3 Phillips-Medisize Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
  78. 6.13.5 Phillips-Medisize Recent Developments
  79. 6.14 Johnson & Johnson
  80. 6.14.1 Johnson & Johnson Company Information
  81. 6.14.2 Johnson & Johnson Business Overview
  82. 6.14.3 Johnson & Johnson Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
  84. 6.14.5 Johnson & Johnson Recent Developments
  85. 6.15 Shandong Weigao
  86. 6.15.1 Shandong Weigao Company Information
  87. 6.15.2 Shandong Weigao Business Overview
  88. 6.15.3 Shandong Weigao Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
  90. 6.15.5 Shandong Weigao Recent Developments
  91. 6.16 Pfizer
  92. 6.16.1 Pfizer Company Information
  93. 6.16.2 Pfizer Business Overview
  94. 6.16.3 Pfizer Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Pfizer Drug Delivery Devices Product Portfolio
  96. 6.16.5 Pfizer Recent Developments
  97. 6.17 B.Braun
  98. 6.17.1 B.Braun Company Information
  99. 6.17.2 B.Braun Business Overview
  100. 6.17.3 B.Braun Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 B.Braun Drug Delivery Devices Product Portfolio
  102. 6.17.5 B.Braun Recent Developments
  103. 6.18 Novartis AG
  104. 6.18.1 Novartis AG Company Information
  105. 6.18.2 Novartis AG Business Overview
  106. 6.18.3 Novartis AG Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Novartis AG Drug Delivery Devices Product Portfolio
  108. 6.18.5 Novartis AG Recent Developments
  109. 6.19 Zhengkang
  110. 6.19.1 Zhengkang Company Information
  111. 6.19.2 Zhengkang Business Overview
  112. 6.19.3 Zhengkang Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Zhengkang Drug Delivery Devices Product Portfolio
  114. 6.19.5 Zhengkang Recent Developments
  115. 6.20 Gerresheimer
  116. 6.20.1 Gerresheimer Company Information
  117. 6.20.2 Gerresheimer Business Overview
  118. 6.20.3 Gerresheimer Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
  120. 6.20.5 Gerresheimer Recent Developments
  121. 6.21 COVIDIEN Medtronic
  122. 6.21.1 COVIDIEN Medtronic Company Information
  123. 6.21.2 COVIDIEN Medtronic Business Overview
  124. 6.21.3 COVIDIEN Medtronic Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
  126. 6.21.5 COVIDIEN Medtronic Recent Developments
  127. 6.22 Schott forma vitrum
  128. 6.22.1 Schott forma vitrum Company Information
  129. 6.22.2 Schott forma vitrum Business Overview
  130. 6.22.3 Schott forma vitrum Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
  132. 6.22.5 Schott forma vitrum Recent Developments
  133. 6.23 Alkermes
  134. 6.23.1 Alkermes Company Information
  135. 6.23.2 Alkermes Business Overview
  136. 6.23.3 Alkermes Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Alkermes Drug Delivery Devices Product Portfolio
  138. 6.23.5 Alkermes Recent Developments
  139. 6.24 Skyepharma
  140. 6.24.1 Skyepharma Company Information
  141. 6.24.2 Skyepharma Business Overview
  142. 6.24.3 Skyepharma Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Skyepharma Drug Delivery Devices Product Portfolio
  144. 6.24.5 Skyepharma Recent Developments
7 North America
  1. 7.1 North America Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug Delivery Devices Market Size by Country (2021-2026)
  3. 7.3 North America Drug Delivery Devices Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug Delivery Devices Market Size by Country (2021-2026)
  3. 8.3 Europe Drug Delivery Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug Delivery Devices Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug Delivery Devices Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug Delivery Devices Market Size by Country (2021-2026)
  3. 10.3 South America Drug Delivery Devices Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug Delivery Devices Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug Delivery Devices Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.